SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-14-037797
Filing Date
2014-02-06
Accepted
2014-02-06 06:15:02
Documents
2
Group Members
AVALON VENTURES IX, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d671083dsc13da.htm SC 13D/A 43205
2 EX-99.J d671083dex99j.htm EX-99.J 181517
  Complete submission text file 0001193125-14-037797.txt   226193
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Subject) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87524 | Film No.: 14577947
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1134 KLINE ST LA JOLLA CA 92037
Business Address 1134 KLINE ST LA JOLLA CA 92037 858-348-2179
Avalon Ventures IX GP, LLC (Filed by) CIK: 0001578781 (see all company filings)

IRS No.: 272359411 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A